Have a feature idea you'd love to see implemented?
Let us know!
ILMN Illumina Inc
Price (delayed)
$136.99
Market cap
$21.73B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$9.95
Enterprise value
$23.46B
Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a
Highlights
The quick ratio has soared by 127% from the previous quarter and by 53% YoY
The gross margin has grown by 4.1% YoY and by 3.1% from the previous quarter
The equity has plunged by 64% YoY but it has increased by 48% from the previous quarter
Illumina's EPS has increased by 48% QoQ but it has decreased by 40% YoY
Key stats
What are the main financial stats of ILMN
Market
Valuations
Earnings
Shares outstanding
158.6M
Market cap
$21.73B
Enterprise value
$23.46B
Price to book (P/B)
10.27
Price to sales (P/S)
4.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.34
Revenue
$4.39B
EBIT
-$1.44B
EBITDA
-$1.05B
Free cash flow
$547M
Per share
Balance sheet
Liquidity
EPS
-$9.95
Free cash flow per share
$3.44
Book value per share
$13.34
Revenue per share
$27.61
TBVPS
$28.91
Total assets
$6.01B
Total liabilities
$3.89B
Debt
$2.6B
Equity
$2.13B
Working capital
$1.4B
Debt to equity
1.22
Current ratio
2.43
Quick ratio
1.68
Net debt/EBITDA
-1.65
Margins
Efficiency
Dividend
EBITDA margin
-23.9%
Gross margin
63.9%
Net margin
-36.1%
Operating margin
-26.7%
Return on assets
-19.6%
Return on equity
-42.1%
Return on invested capital
-31.8%
Return on capital employed
-28.6%
Return on sales
-32.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ILMN stock price
How has the Illumina stock price performed over time
Intraday
4.03%
1 week
-3.69%
1 month
-5.66%
1 year
42.74%
YTD
-1.62%
QTD
5.05%
Financial performance
How have Illumina's revenue and profit performed over time
Revenue
$4.39B
Gross profit
$2.81B
Operating income
-$1.17B
Net income
-$1.58B
Gross margin
63.9%
Net margin
-36.1%
Illumina's operating margin has soared by 56% from the previous quarter but it has decreased by 16% YoY
The operating income has soared by 56% from the previous quarter but it has decreased by 13% YoY
ILMN's net income is up by 48% since the previous quarter but it is down by 41% year-on-year
Illumina's net margin has increased by 47% QoQ but it has decreased by 43% YoY
Growth
What is Illumina's growth rate over time
Valuation
What is Illumina stock price valuation
P/E
N/A
P/B
10.27
P/S
4.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.34
Illumina's EPS has increased by 48% QoQ but it has decreased by 40% YoY
The equity has plunged by 64% YoY but it has increased by 48% from the previous quarter
The price to book (P/B) is 43% higher than the last 4 quarters average of 7.2 and 39% higher than the 5-year quarterly average of 7.4
ILMN's P/S is 51% below its 5-year quarterly average of 10.1 but 8% above its last 4 quarters average of 4.6
Efficiency
How efficient is Illumina business performance
The ROE has plunged by 141% YoY but it has grown by 35% from the previous quarter
The company's return on assets has shrunk by 100% YoY but it rose by 41% QoQ
ILMN's return on invested capital has surged by 54% since the previous quarter but it is down by 35% year-on-year
Illumina's return on sales has surged by 51% QoQ but it has decreased by 40% YoY
Dividends
What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ILMN.
Financial health
How did Illumina financials performed over time
The total assets is 55% more than the total liabilities
The quick ratio has soared by 127% from the previous quarter and by 53% YoY
The current ratio has soared by 119% from the previous quarter and by 44% YoY
Illumina's debt is 22% higher than its equity
The equity has plunged by 64% YoY but it has increased by 48% from the previous quarter
The debt to equity is down by 38% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.